( Peptide InnOvatioN for the Early diabetEs tReatment (PIONEER) trial showed that GLP-1RAs caused an overall nausea rate of 15-20% and were associated with gastrointestinal adverse events, but these were temporary and dose-dependent ( Underlying mechanism The mechanisms that contribute to the beneficial effects of SGLT2i and GLP-1RAs in patients with T2DM have been extensively studied
Sulforaphane and bladder cancer: a potential novel antitumor compound
To qualify for weight loss medications under Bridge, you need to meet certain BMI thresholds
Your immune system marks these foreign invaders as pathogens and attacks them
People with compromised immune systems : Conditions like HIV, cancer treatments, or other immune system disorders can result in reduced glutathione levels, impacting the bodys ability to fight infections and heal
Thyroid removal eliminates thyroid hormone production, requiring lifelong levothyroxine or combination hormone therapy, which directly affects metabolic rate, weight regulation, and medication safety
